Danbee Kang

5.8k citations
258 papers · 4.1k · 1 hit paper · h-index 32

Impact in

  • Oncology top 5%
    • Cancer survivorship and care
    • Liver Disease Diagnosis and Treatment
    • Sepsis Diagnosis and Treatment

Papers in

Danbee Kang

225 papers receiving 4k citations

Danbee Kang's Hit Papers

Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial 2025 · 46 citations
460Years since publication10203040

Peers

Danbee Kang
Comparison fields: 5 of 124
  • Oncology 688
  • Epidemiology 864
  • Hepatology 224
  • Dermatology 192
  • Pulmonary and Respiratory Medicine 611
Replace Martin Soubrier with:
Martin Soubrier France
Andreas Oliver Zuckermann Austria
Steen Ladelund Denmark
Sandrine Touzet France
Tim R Card United Kingdom
Ross Dierkhising United States
Wanderley Marques Bernardo Brazil
Abbas Kezouh Canada
M. Sesmu Arbous Netherlands
Shih‐Chieh Shao Taiwan
Danbee Kang relative to Martin Soubrier France Martin Soubrier's profile →
Citations per field
00.5×2×3.2×
Martin Soubrier · 1×
Citations per year

Countries citing papers authored by Danbee Kang

Since Specialization
Citations

This map shows the geographic impact of Danbee Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danbee Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danbee Kang more than expected).

Fields of papers citing papers by Danbee Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danbee Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danbee Kang. The network helps show where Danbee Kang may publish in the future.

Co-authors

The 25 scholars most cited alongside Danbee Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Danbee Kang Line = papers co-authored together Danbee Kang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 258 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014174
2 2016138
3 2017138
4 2018132
5 2022110
6 2016100
7 201999
8 202086
9 202079
10 201876
11 201875
12 202071
13 201570
14 201868
15 201863
16 202155
17 201851
18 201951
19 201550
20 201748

About Danbee Kang

Danbee Kang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Cardiology and Cardiovascular Medicine and Dermatology, having authored 258 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer survivorship and care (45 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers), Liver Disease Diagnosis and Treatment (15 papers), Lung Cancer Diagnosis and Treatment (15 papers), Chemotherapy-related skin toxicity (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Acute Myocardial Infarction Research (7 papers) and Mobile Health and mHealth Applications (7 papers). The work is most often cited by research in Oncology (688 citations), Epidemiology (864 citations), Hepatology (224 citations), Dermatology (192 citations) and Pulmonary and Respiratory Medicine (611 citations). Danbee Kang has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Juhee Cho, Eliseo Güallar, Dong Hyun Sinn, Geum‐Youn Gwak, Yoosoo Chang, Seungho Ryu, Hye Yun Park, Seung Woon Paik, Soo Jin Cho and Nayeon Kim. Their work appears in journals such as Scientific Reports, Supportive Care in Cancer, PLoS ONE, Cancer Research and Treatment and Respiratory Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact